MEKK2 mediates aberrant ERK activation in neurofibromatosis type I

por Bok, Seoyeon, Shin, Dong Yeon, Yallowitz, Alisha R., Eiseman, Mark, Cung, Michelle, Xu, Ren, Li, Na, Sun, Jun, Williams, Alfred L., Scott, John E., Su, Bing, Shim, Jae-Hyuck, Greenblatt, Matthew B.
Publicado 2020

CHMP5 controls bone turnover rates by dampening NF-κB activity in osteoclasts

por Greenblatt, Matthew B., Park, Kwang Hwan, Oh, Hwanhee, Kim, Jung-Min, Shin, Dong Yeon, Lee, Jae Myun, Lee, Jin Woo, Singh, Anju, Lee, Ki-young, Hu, Dorothy, Xiao, Changchun, Charles, Julia F., Penninger, Josef M., Lotinun, Sutada, Baron, Roland, Ghosh, Sankar, Shim, Jae-Hyuck
Publicado 2015

SLITRK5 is a negative regulator of hedgehog signaling in osteoblasts

por Sun, Jun, Shin, Dong Yeon, Eiseman, Mark, Yallowitz, Alisha R., Li, Na, Lalani, Sarfaraz, Li, Zan, Cung, Michelle, Bok, Seoyeon, Debnath, Shawon, Marquez, Sofia Jenia, White, Tommy E., Khan, Abdul G., Lorenz, Ivo C., Shim, Jae-Hyuck, Lee, Francis S., Xu, Ren, Greenblatt, Matthew B.
Publicado 2021

Targeting skeletal endothelium to ameliorate bone loss

por Xu, Ren, Yallowitz, Alisha, Qin, An, Wu, Zhuhao, Shin, Dong Yeon, Kim, Jung-Min, Debnath, Shawon, Ji, Gang, Bostrom, Mathias P., Yang, Xu, Zhang, Chao, Dong, Han, Kermani, Pouneh, Lalani, Sarfaraz, Li, Na, Liu, Yifang, Poulos, Michael G., Wach, Amanda, Zhang, Yi, Inoue, Kazuki, Di Lorenzo, Annarita, Zhao, Baohong, Butler, Jason M., Shim, Jae-Hyuck, Glimcher, Laurie H., Greenblatt, Matthew B.
Publicado 2018